Nanoshell

Medical

Medical

 
medic-563423_1920.jpg

Improved Blood Purification System

Hemolytic conditions result in a glut of toxic free hemoglobin and iron that cause secondary effects in addition to those of the primary disease. To combat these issues, patients undergo regular red blood cell exchange and plasmapheresis which are only partially successful in controlling the problem. Supplementary drug therapy comes with its own complications. We have developed a patent-pending nanoparticle-enhanced high-throughput extracorporeal blood cleaning system. This system quickly and efficiently removes target substances from circulating blood during regular red blood cell exchange and plasmapheresis, leaving the patient blood in much improved condition. This is a complementary system whose intent is to reduce the frequency and severity of unexpected crisis events, and prolong the time between needed transfusions. We are currently engaged in early clinical testing of this system, and updates will be posted on our web site regularly.

more info: info@nanoshellcompany.com

 
blood-17305_1920.jpg

High Throughput Cell Collection System

Liquid biopsy provides valuable information about the nature of disease and helps define subsequent course of treatment for cancer patients. Related to this technology, we have developed a high throughput cellular collection system coupled to clinical aphaeresis that can have therapeutic benefits. This patent-pending technology can process large volumes of patient blood in short time and collect target cells from the blood circulation. This treatment can enhance the effectiveness of chemotherapy and radiation therapy to stop the spread of disease to other sites in the body.

more info: info@nanoshellcompany.com